Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ligand Pharmaceuticals (LGND) Interest & Investment Income (2017 - 2025)

Historic Interest & Investment Income for Ligand Pharmaceuticals (LGND) over the last 12 years, with Q3 2025 value amounting to $3.9 million.

  • Ligand Pharmaceuticals' Interest & Investment Income rose 18760.21% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.2 million, marking a year-over-year increase of 1765.38%. This contributed to the annual value of $8.1 million for FY2024, which is 446.12% up from last year.
  • As of Q3 2025, Ligand Pharmaceuticals' Interest & Investment Income stood at $3.9 million, which was up 18760.21% from $1.6 million recorded in Q2 2025.
  • Ligand Pharmaceuticals' 5-year Interest & Investment Income high stood at $3.9 million for Q3 2025, and its period low was $134000.0 during Q1 2022.
  • Its 5-year average for Interest & Investment Income is $1.4 million, with a median of $1.4 million in 2023.
  • In the last 5 years, Ligand Pharmaceuticals' Interest & Investment Income crashed by 9374.21% in 2021 and then soared by 97089.55% in 2023.
  • Quarter analysis of 5 years shows Ligand Pharmaceuticals' Interest & Investment Income stood at $188000.0 in 2021, then soared by 444.15% to $1.0 million in 2022, then skyrocketed by 65.49% to $1.7 million in 2023, then grew by 14.06% to $1.9 million in 2024, then surged by 100.62% to $3.9 million in 2025.
  • Its Interest & Investment Income was $3.9 million in Q3 2025, compared to $1.6 million in Q2 2025 and $1.8 million in Q1 2025.